Drug intelligence / Profile preview

amiloride + enalapril

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Amiloride + enalapril is a combination of two antihypertensive agents used together to manage high blood pressure (hypertension) and, in some cases, heart failure. Amiloride is a potassium-sparing diuretic that acts on the distal renal tubules to inhibit sodium reabsorption while reducing potassium excretion. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor prodrug that blocks the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced aldosterone-mediated sodium retention. The combination may be considered in patients who require both mechanisms for optimal blood pressure control but must be used with caution due to the risk of hyperkalemia from additive effects on potassium retention[3][4][6]. This combination does not have a widely recognized fixed-dose brand formulation but may be prescribed as separate agents.

02

Targets

ACE (Angiotensin Converting Enzyme)ENaC

Beyond the preview

Go deeper on amiloride + enalapril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amiloride + enalapril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call